文献速递产科母胎医学

定制GROW与INTERGROWTH-21st出生体重标准识别足月小于胎龄儿相关围产结局的比较

Customized GROW vs INTERGROWTH-21st birthweight standards to identify small for gestational age associated perinatal outcomes at term.
PubMed 文献 · Am J Obstet Gynecol MFM · 2021-12-04

本回顾性队列研究基于多中心围产质量改进项目2012至2017年125826例分娩数据,其中92622例足月单胎有完整结局数据,比较定制GROW与INTERGROWTH-21st标准识别小于胎龄儿相关围产疾病和死亡的能力。GROW与INTERGROWTH-21st分别将9578例(10.3%)和4079例(4.4%)妊娠归类为小于胎龄儿,GROW识别出更多合并不良结局的小于胎龄儿。

要点

  • GROW与INTERGROWTH-21st分别将9578例(10.3%)和4079例(4.4%)妊娠归类为小于胎龄儿。
  • GROW识别出更多合并不良结局的小于胎龄儿,包括死产、围产期死亡、低Apgar评分等。
  • 27例死产中13例(48%)被GROW识别为小于胎龄儿而INTERGROWTH-21st未识别。

核心结论

  • 使用GROW进行定制评估可增加对足月小于胎龄儿的识别,这些婴儿面临一系列不良妊娠结局的显著增加风险。

研究设计与样本

  • 本回顾性队列研究使用多中心围产质量改进项目数据,包含2012至2017年125826例分娩的多族裔数据集。
  • 92622例足月单胎有完整结局数据,包括死产、新生儿死亡、5分钟Apgar评分<7、新生儿血糖不稳定及需转至更高级别护理或新生儿重症监护病房。
  • 应用定制GROW与INTERGROWTH-21st出生体重标准,按各自方法和公式判定小于胎龄儿(<第10百分位)。

主要发现

  • GROW与INTERGROWTH-21st分别将9578例(10.3%)和4079例(4.4%)妊娠归类为小于胎龄儿。
  • 对所有评估结局,GROW识别出更多合并不良结局的小于胎龄儿,包括更多死产、围产期死亡、低Apgar评分、血糖不稳定、新生儿惊厥及转至更高级别护理。
  • 27例死产中13例(48%)被任一方法判为小于胎龄儿者,被GROW识别为小于胎龄儿而INTERGROWTH-21st未识别。
  • INTERGROWTH-21st仅在1个类别(血糖不稳定)中识别出295例中的9例(3.1%)未被GROW判为小于胎龄儿的病例。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fetal growth restriction is associated with stillbirth and other adverse pregnancy outcomes, and the use of the correct weight standard is an essential proxy indicator of growth status and perinatal risk. OBJECTIVE: This study aimed to assess the performance of two international birthweight standards for their ability to identify perinatal morbidity and mortality indicators associated with small for gestational age infants at term. STUDY DESIGN: This retrospective cohort study used data from a multicenter perinatal quality initiative, including a multiethnic dataset of 125,826 births from 2012 to 2017. Of the singleton term births, 92,622 had complete outcome data including stillbirth, neonatal death, 5-minute Apgar score <7, neonatal glucose instability and need for newborn transfer to a higher level of care or neonatal intensive care unit admission. The customized GROW and INTERGROWTH-21st birthweight standards were applied to determine small for gestational age (<10th percentile) according to their respective methods and formulae. The associations with adverse outcomes were expressed as relative risks with 95% confidence intervals and population attributable fractions. RESULTS: GROW and INTERGROWTH-21st classified 9578 (10.3%) and 4079 (4.4%) pregnancies as small for gestational age, respectively. For all of the outcomes assessed, GROW identified more small for gestational age infants with adverse outcomes than INTERGROWTH-21st, including more stillbirths, perinatal deaths, low Apgar scores, glucose instability, newborn seizure, and transfers to a higher level of care. Moreover, 13 of 27 stillbirths (48%) that were small for gestational age by either method were identified as small for gestational age by GROW but not by INTERGROWTH-21st. Similarly, additional cases of all other adverse outcome indicators were identified by GROW as small for gestational age, whereas INTERGROWTH-21st identified in only 1 category (glucose instability) 9 of 295 cases (3.1%), which were not identified as small for gestational age by GROW. CONCLUSION: Customized assessment using GROW resulted in increased identification of small for gestational age term infants that were at significantly increased risk of an array of adverse pregnancy outcomes.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Fay E, Hugh O, Francis A, et al. Customized GROW vs INTERGROWTH-21st birthweight standards to identify small for gestational age associated perinatal outcomes at term. Am J Obstet Gynecol MFM. 2021. PMID: 34875415. doi:10.1016/j.ajogmf.2021.100545

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。